All attending UK organisations

UK companies attending Bio-Europe Spring 2014

UK stand (booth 44)
BIA (UK BioIndustry Association), Bionow, BioPartner UK, Clinical Network Services, Epistem, Novozymes Biopharma, One Nucleus, Simbec Research, Sphere Fluidics, Sygnature Discovery
(Click here to search profiles)

UK Exhibitors
BioPartner and UK delegation #44; Abcam #51, Cobra Biologics #50, Evaluate Pharma #7, Fujifilm Diosynth #61, Randox #39, Scottish Development International #26b

Scottish stand (booth #26b)
Scottish Development International, Aptuit Glasgow, Bioascent Discovery, Charles River, Industrial Biotechnology Innovation Centre (IBioIC), Ockham Oncology, Symbiosis Pharmaceutical Services, Tc Biopharm, TPP Global Development, University of Edinburgh, University of Strathclyde.

UK Presenting companies:
Convergence Pharmaceuticals, Crescendo Biologics, Edinburgh Bioquarter, GT Biologics, Shire Pharmaceutical, TC Biopharm, Theradex Europe, Therakind, University of Nottingham, Warner Chilcott UK

All UK organisations:
3M Health Care, Abcam, Alcyomics, Allergan, Almac Group, Amdipharm, Apex Healthcare, Aptuit, Argenta, Astellas Pharmaceuticals, Aston University, Astrazeneca, Atebion, Atlantic Healthcare, Autifony Therapeutics, Avacta Analytical, BDO, BIA, BioAscent Discovery, Biocatalysts, BioPartner UK, BioPharm Insight,  Biotecnol, Britannia Pharmaceuticals, Cancer Research Technology, Celerion, Charles River, Clinical Network Services (UK), Cmed Clinical Services, Cobra Biologics, Convergence Pharmaceuticals, Coulter Partners, Covance, Covington & Burling, Crescendo Biologics, Current Partnering, Cyclofluidic, Decision Resources Group, Diamond Biopharm, Domainex, Durbin PLC, EBR, Edinburgh BioQuarter, Eisai, Eli Lilly and Company , Epistem, EP Vantage,  ERA Consulting UK, Ergomed Clinical Research , Evaluate, Ferghana Partners, Forest Laboratories, F-star Biotechnology, FTS Bio, Fujifilm Diosynth Biotechnologies, GE Healthcare, Gilead Sciences, Glide Pharma, GlobalData, Glythera, Granta Park, GT Biologics, GW Pharmaceuticals, Health Research Wales, Heptares Therapeutics, Hitgen, Horizon Discovery, Houston-Harvey Associates, IBioIC, Imanova, Immune Targeting Systems (ITS), IMS Health, Index Ventures, Informa, Innova Biosciences, Invest in Oxfordshire, J A Kemp, Jazz Pharmaceuticals, Johnson & Johnson Innovation, Key Organics, KWS BioTest, Kymab , Leviset, Liftstream, Longcross Advisers LLP, MedImmune, Medius Associates, MedPharm, Motac, Mundipharma International, Nanomerics, Nature Publishing Group, NC3Rs, NDA Group, Norgine, Nova Language Services, Novasecta, Novozymes Biopharma UK, OBN, Ockham Oncology, One Nucleus, Ono Pharma UK, Oxford Biomedica, Oxford BioTherapeutics, Parkinson's UK, Patheon, Pharma eTrack, Pharmaterials, PharmaVentures, Polytherics, PRA, Present Value, Probe Scientific, Proimmune, ProPharma Partners, ProStrakan, Q-Chip, Quintiles, R&D Focus, Randox Life Sciences, Redx Pharma, ReNeuron, Retroscreen, RRG, Sage Healthcare, Saretius, Sareum, Scottish Development International, SEEK Group (PepTcell ), Sharp Clinical Services, Shionogi , Shire Pharmaceutical, Sigma-Aldrich, Simbec Research, Sphere Fluidics, Stelfox, Summit, Sygnature Discovery, Symbiosis Pharmaceutical Services, SYNthesis med chem (UK), Taylor Wessing, TC BioPharm, Teijin Pharma, Tekcapital, Teva UK, The Institute of Cancer Research, Theradex Europe, Therakind, Torreya Partners, TPP Global Development, Tukan Partners, UKTI, University of Edinburgh, University of Nottingham, University of Strathclyde, ValiRx, Warner Chilcott UK, Xention.

 Join them here!

updated 6th March 2014

*BioPartnership Programme members are hyperlinked